C. Gargalidismoudanos et al., PREDOMINANT EXPRESSION OF MONOAMINE-OXIDASE-B ISOFORM IN RABBIT RENALPROXIMAL TUBULE - REGULATION BY I-2 IMIDAZOLINE LIGANDS IN INTACT-CELLS, Molecular pharmacology, 51(4), 1997, pp. 637-643
Previous studies have shown that a subpopulation of the catecholamine-
degrading enzymes monoamine oxidase (MAO) A and B holds a previously u
nknown regulatory site, the I-2-imidazoline binding site (I2BS). In th
e present work, we characterized the isoforms of monoamine oxidases ex
pressed in the rabbit renal proximal tubule, defined their relationshi
p with I2BS, and investigated the ability of I2BS ligands to inhibit e
nzyme activity in intact cells. Two findings indicate that MAO-B is th
e predominant isoform expressed in the renal proximal tubule cells: 1)
Western blot performed with an anti-MAO-A/MAO-B polyclonal antiserum
revealed a single 55-kDa band corresponding to MAO-B; 2) enzyme assays
showed an elevated MAO-B activity ([C-14]beta-phenylethylamine oxidat
ion: V-max = 1.31 +/- 0.41 nmol/min/mg protein), whereas MAO-A activit
y was only detectable ([C-14]5-HT oxidation: V-max = 80.3 +/- 19 pmol/
min/mg protein). Photoaffinity labeling with the I2BS ligand [I-125]2-
(3-azido-4-iodophenoxy)-methylim revealed a single 55-kDa band, which
indicates that MAO-B of the renal proximal tubule cells holds the I-2
imidazoline binding site. [H-3]Idazoxan binding studies and enzyme ass
ays showed that, in intact cells, I2BS ligands bind to and inhibit MAO
-B. Indeed, the increase in the accessibility of intracellular compart
ment by cell permeabilization did not enhance [H-3]idazoxan binding, w
hich indicates that, in intact cells, intracellular I2BS are fully occ
upied by imidazoline ligands. In addition, enzyme assays showed that i
ncubation of proximal tubule cells with imidazoline ligands leads to a
complete, dose-dependent inhibition of MAO activity. These data show
the predominant expression of MAO-B in rabbit renal proximal tubule an
d its regulation by imidazoline ligands in intact cells.